The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 17, 2021

Filed:

Jan. 24, 2020
Applicant:

Redhill Biopharma Ltd., Tel-Aviv, IL;

Inventors:

Reza Fathi, Oradell, NJ (US);

Dror Ben-Asher, Tel-Aviv, IL;

Guy Goldberg, Tel-Aviv, IL;

Assignee:

RedHill Biopharma Ltd., Tel-Aviv, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4409 (2006.01); A61K 31/438 (2006.01); A61K 31/7048 (2006.01); A61P 31/14 (2006.01); A61K 31/435 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7048 (2013.01); A61K 31/435 (2013.01); A61K 31/438 (2013.01); A61K 31/4409 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01);
Abstract

Pharmaceutical compositions showing the ability to inhibit or suppress replication of a filovirus in an individual are disclosed. The disclosed compositions are useful for treating, reventing, or reducing the spread of infections by filovirus. A method includes administering at least one agent of the present disclosure to an individual infected with or exposed to a filovirus, wherein the step of administering is carried out for a suitable time period so that the individual is treated; and determining whether the individual has been treated, wherein the step of determining includes one of measuring an inhibition in viral replication, measuring a decrease in viral load, or reducing at least one symptom associated with the filovirus.


Find Patent Forward Citations

Loading…